Navigation Links
Microbiologists receive top Canadian recognition
Date:5/8/2008

One is a veteran researcher, the other new, but two microbiologists from The University of Western Ontario have both been singled out to receive national recognition for their work on infectious diseases and immunity from the Canadian Society of Microbiologists (CSM).

Dr. Miguel Valvano, a professor and Chair of the Department of Microbiology and Immunology at the Schulich School of Medicine & Dentistry received the prestigious CSM/Roche Diagnostics Award for outstanding accomplishments and Dr. John McCormick, an assistant professor in the Department of Microbiology received the Fisher Scientific Award for new researchers in microbiological sciences.

Valvano, who also holds a Canada Research Chair in Infectious Diseases and Microbial Pathogenesis, received his M.D. from the University of Buenos Aires, and trained as paediatrician and infectious diseases specialist in the Buenos Aires Childrens Hospital, and later as a molecular biologist in the Oregon Health Sciences University, before joining Western in 1988. His team discovered the way to kill B. cenocepacia, a superbug which can be highly contagious and deadly for those with cystic fibrosis. This discovery paves the way for the development of new antibiotics to treat it, as well as a vaccine to prevent it. We are investigating how bacteria make their outer surface and how can we find novel ways to interfere with this process, says Valvano.

A critical aspect of our research is also to train graduate students and postdoctoral fellows to become outstanding biomedical scientists within an environment of scientific inquiry, and particularly placing an emphasis on personal and scientific integrity and on team player skills.

McCormick received his Ph.D. from the University of Alberta and continued post-doctoral training in the U.S. before coming to Western in 2002. McCormick is also a scientist with the Lawson Health Research Institute and he holds a New Investigator award from the Canadian Institutes of Health Research and an Early Research award from the Ontario Ministry of Research and Innovation. Our research focuses primarily on a group of toxins called superantigens that are produced by the bacterial pathogens Streptococcus pyogenes and Staphylococcus aureus. These toxins induce a dramatic activation of the immune system and can cause a rare but very dangerous disease called toxic shock syndrome, explains McCormick. We use a number of advanced techniques in molecular biology, genetics, bacteriology, and immunology, to understand how these toxins function at a very detailed level, such that we rationally design inhibitors of their function, and also so that we can harness their function for immune based therapeutics.

The scientists will receive their awards June 9th in Calgary.


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. U.S. Navy Receives Funding for Further Development of Hemopure(R)
2. UCSF receives funding for building from California stem cell agency
3. USC receives nearly $27 million in funding for new stem cell research facility
4. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
5. Presbyterian Hospital of Plano Receives Prestigious Texas Award for Performance Excellence
6. Boston Medical Center/Boston University School of Medicine researcher receives award
7. Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
8. Hospitals in Louisiana and Mississippi to Receive More Katrina Recovery Grants
9. Quatro Composites Receives ISO 9001:2000 and AS9100:2004 Certification
10. Vascular Insights Receives FDA Clearance for Infusion Catheter
11. Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... uncovers what he says are the real facts surrounding all those Bible stories. For ... and Sunday school teachers, and Yisrayl says there is more to these than just ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Dignity Health ... General Hospital Emergency Room –Mesa. The new facility is licensed under Dignity ... , “Dr. Bingham is an excellent leader and will ensure our new freestanding emergency ...
(Date:2/11/2016)... ... 11, 2016 , ... SPH Analytics announced today that ... health solutions, MDinsight® and IndiGO®, for its primary care clinicians. The 3-year partnership ... the contract were not disclosed. , As the healthcare market moves towards quality-based ...
(Date:2/11/2016)... ... , ... Florida Hospital presents Heart Health Awareness night on Sunday February 14th, ... Amalie Arena. The puck drops at 6:00pm, but fans will have the opportunity to ... the game. The MEGA Heart will be located on Ford Thunder Alley and provide ...
(Date:2/11/2016)... Chicago, IL (PRWEB) , ... February 11, 2016 ... ... dedicated to the healthcare industry, ranked among the top five firms in the ... Services and HIT Implementation Support and Staffing. KLAS is a research and insights ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  SI-BONE, Inc., a medical device company ... ("iFuse"), a minimally invasive surgical (MIS) device indicated for fusion for ... Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... and SEOUL, South Korea ... Menarini and Macrogen, Inc. today announced they will ... innovative procedures for precision medicine in cancer. The ... Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput Next ... certified under the Clinical Laboratory Improvement Amendments (CLIA) ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
Breaking Medicine Technology: